Total Raised

$2.38M

Investors Count

2

Funding, Valuation & Revenue

4 Fundings

PastRx has raised $2.38M over 4 rounds.

PastRx's latest funding round was a Incubator/Accelerator for on November 5, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/5/2017

Incubator/Accelerator

$XXM

0

FY undefined

1

2/24/2017

Debt - II

$XXM

$XXM

0

FY undefined

10

10/21/2015

Unattributed

$XXM

$XXM

0

FY undefined

10

2/19/2015

Debt

$XXM

$XXM

0

FY undefined

10

Date

11/5/2017

2/24/2017

10/21/2015

2/19/2015

Round

Incubator/Accelerator

Debt - II

Unattributed

Debt

Amount

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

Start free trial
New call-to-action

PastRx Investors

2 Investors

PastRx has 2 investors. DreamIt Ventures invested in PastRx's Incubator/Accelerator funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/5/2017

11/5/2017

1
Incubator/Accelerator

Venture Capital

Pennsylvania

00/00/0000

00/00/0000

Ben Franklin Technology Partners of Southeastern Pennsylvania

Subscribe to see more

Public-Private Partnership

Pennsylvania

First funding

11/5/2017

00/00/0000

Last Funding

11/5/2017

00/00/0000

Investor

Ben Franklin Technology Partners of Southeastern Pennsylvania

Rounds

1
Incubator/Accelerator

Subscribe to see more

Board Seats

Type

Venture Capital

Public-Private Partnership

Location

Pennsylvania

Pennsylvania

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.